Related by context. Frequent words. (Click for all words.) 57 Preclinical Data 57 Clinical Trial Results 57 Drug Candidate 57 Surgical Treatment 57 Novel Approach 56 Diagnostic Tests 56 Hepatocellular Carcinoma 56 Malaria Vaccine 55 Study Demonstrates 55 Polymorphism 55 Cancer Vaccines 55 Metastatic Colorectal Cancer 55 Gastric Cancer 55 Phase III Clinical Trial 55 Brain Cells 55 Phase III Trial 55 Heart Failure Patients 54 FDA Clearance 54 Gene Mutation 54 Autoimmune Disease 54 Small Molecule 54 Non Invasive 54 Pivotal Trial 54 Improves Survival 54 Urinary Incontinence 54 Cancer Treatments 54 Meta Analysis 54 Prostate Cancer Treatment 54 Holds Promise 54 Patient Enrollment 54 SMi 54 Pivotal Study 54 Bladder Cancer 54 Immune Cells 54 Autoimmune Diseases 54 Monoclonal Antibody 53 Pulmonary Arterial Hypertension 53 Blood Vessels 53 Elderly Patients 53 Patent Covering 53 Venous Thromboembolism 53 Practical Approach 53 Different Types 53 Patient Outcomes 53 Survival Rates 53 RNAi Therapeutics 53 Patients Undergoing 53 Renal Cell Carcinoma 53 Peer Reviewed 53 Multicenter 53 Gender Differences 53 Advanced Prostate Cancer 53 Early Diagnosis 52 Innovative Approach 52 Cognitive Function 52 Cancer Therapies 52 Clinical Documentation 52 Autoimmunity 52 Phenotype 52 Inhibits 52 Electroporation 52 Prostate Cancer Patients 52 Well Tolerated 52 Oxidative Stress 52 Patent Issued 52 Acute Ischemic Stroke 52 BERKELEY CA UroToday.com 52 Better Outcomes 52 Antigens 52 Embryonic Stem Cells 52 Targeted Therapy 52 Systematic Review 52 Smallpox Vaccine 52 Newly Diagnosed 52 Neuropathic Pain 52 Screening Tool 52 Competitive Advantages 52 Malignancies 52 Significantly Improves 52 Amino Acid 52 Fully Automated 52 Acute Myocardial Infarction 52 Metastatic Melanoma 52 Help Predict 52 Virtual Colonoscopy 51 StockSource.us Reports 51 Overactive Bladder 51 Allograft 51 Solid Tumors 51 Face Transplant 51 Bone Mineral Density 51 Low Dose 51 Exclusive License 51 Flagship Product 51 Achieves Milestone 51 Breast Cancer Treatment 51 Analogs 51 Combination Therapy 51 Monoclonal Antibodies 51 Clinical Study 51 ASH Annual Meeting